Skip to Main Content

Hello, everyone, and welcome to the middle of the week. You made it this far, so why not continue, yes? Perhaps a cup or two of stimulation is in order to celebrate this feat. As you know, a prescription is not required. Meanwhile, we are happy to report that the faint sounds of chirping birds can be heard on the Pharmalot campus, a sure sign that … snow could return to our part of the world, anyway? Well, while you ponder the possibilities, here are some tidbits to keep you focused. Hope you have a smashing day and, as always, do drop us a line when you hear something interesting …

Pfizer (PFE) is in talks with Procter & Gamble (PG) on the sale of its consumer products business, CNBC tells us. Over the past month, GlaxoSmithKline, Reckitt Benckiser, and Johnson & Johnson have already looked at the business, which sells Chapstick lip balm, Advil pain reliever, and Centrum vitamins. P&G remains the one potential bidder, though the two sides are far apart on price, with P&G looking to pay $15 billion, while Pfizer was seeking $20 billion or more. The pharmaceutical giant hopes to reach a decision by the end of the month.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!